Furthermore, ChIP assays performed on clinical cervical cancer tissues (T1, T2 and T3, see Fig. 3) revealed significantly enhanced ZNF384 occupancy at the INTS13 promoter locus in contrast to adjacent paracancerous cervical tissues (N1, N2, and N3) (Fig. 9H). The gene discussed is ZNF384; the disease is cervical cancer.